Postępy w Kardiologii Interwencyjnej

Association between fibrosis-4 index and 30-day all-cause mortality in critically ill patients hospitalised with acute heart failure: a retrospective cohort study from the MIMIC-IV database

Xiaotian Ren 1
,
Lei Li 1
,
Fei Liu 1
,
Ye Zhu 2

  1. Department of Cardiology, Jiangdu People’s Hospital of Yangzhou, Yangzhou, China

  2. Department of Cardiology, Subei People’s Hospital of Jiangsu Province, Yangzhou, China

Adv Interv Cardiol

DOI: https://doi.org/10.5114/aic.2026.163808
Data publikacji online: 2026/08/03
Article files
Association between.pdf Association between - Supplementary Tables.pdf
  1. McDonagh TA, Metra M, Adamo M, et al. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2023; 44: 3627-39.
  2. Bauersachs J, de Boer RA, Lindenfeld J, Bozkurt B. The year in cardiovascular medicine 2021: heart failure and cardiomyopathies. Eur Heart J 2022; 43: 367-76.
  3. Salimian S, Virani SA, Roston TM, et al. Impact of the method of calculating 30-day readmission rate after hospitalization for heart failure. Data from the VancOuver CoastAL Acute Heart Failure (VOCAL-AHF) registry. Eur Heart J Qual Care Clin Outcomes 2024; 10: 523-30.
  4. Gkantzios A, Tsiptsios D, Karatzetzou S, et al. Stroke and Emerging blood biomarkers: a clinical prospective. Neurol Int 2022; 14: 784-803.
  5. Yao H, Cottin Y, Chagué F, et al. Diagnostic and prognostic impact of new pathophysiology-based categorization of type 1 and type 2 myocardial infarction: data from the French RICO survey. Am Heart J 2023; 266: 86-97.
  6. Kamran H, Tang WHW. Medical management of acute heart failure. Faculty Rev 2021; 10: 82.
  7. Singh G, Bamba H, Inban P, et al. The role of biomarkers in the prognosis and risk stratification in heart failure: a systematic review. Dis Mon 2024; 70: 101782.
  8. Cordero A, Escribano D, Quintanilla MA, et al. Prognostic value of liver fibrosis assessed by the FIB-4 index in patients with acute coronary syndrome. Rev Esp Cardiol 2023; 76: 618-25.
  9. Raposeiras-Roubín S, Parada Barcia JA, Lizancos Castro A, et al. Liver fibrosis and outcomes of atrial fibrillation: the FIB-4 index. Clin Res Cardiol 2024; 113: 313-23.
  10. Adams A, Olesky CL, Fisher A, Justice SB. Acute heart failure. Adv Emerg Nurs J 2022; 44: 178-89.
  11. Maeda D, Kanzaki Y, Sakane K, et al. Prognostic value of the liver fibrosis marker fibrosis-5 index in patients with acute heart failure. ESC Heart Fail 2022; 9: 1380-7.
  12. Liu X, Zhang HJ, Fang CC, et al. Association between noninvasive liver fibrosis scores and heart failure in a general population. J Am Heart Assoc 2024; 13: e035371.
  13. Gaggini M, Minichilli F, Gorini F, et al. FIB-4 index and neutrophil-to-lymphocyte-ratio as death predictor in coronary artery disease patients. Biomedicines 2022; 11: 76.
  14. Cotter G, Davison B, Chioncel O. Enhanced decongestive therapy in patients with acute heart failure: JACC review topic of the week. J Am Coll Cardiol 2024; 83: 1243-52.
  15. Chen M, Guo C, Ouyang K, Liu N. Diagnostic role of the fibrosis-4 index and nonalcoholic fatty liver disease fibrosis score as a noninvasive tool for liver fibrosis scoring. Medicine 2024; 103: e40214.
  16. Nakashima M, Sakuragi S, Miyoshi T, et al. Fibrosis-4 index reflects right ventricular function and prognosis in heart failure with preserved ejection fraction. ESC Heart Fail 2021; 8: 2240-7.
  17. Buzas R, Ciubotaru P, Faur AC, et al. Correlation of the FIB-4 liver biomarker score with the severity of heart failure. Medicina 2024; 60: 1943.
  18. Maeda D, Sakane K, Ito T, et al. Fibrosis-4 index reflects right-sided filling pressure in patients with heart failure. Heart Vessels 2020; 35: 376-83.
  19. Zeder K, Mak S, Galie N, et al. Right heart catheterization in heart failure: indications, interpretation, and pitfalls. Eur Heart J 2025; 46: 3354-72.
  20. Guo Z, Ye Z, Xu Q, et al. Association of liver fibrosis scores with all-cause and cardiovascular mortality in patients with heart failure. Clin Transl Sci 2024; 17: e70104.
  21. Okamoto C, Tsukamoto O, Hasegawa T, et al. Candidate screening for heart failure with preserved ejection fraction clinic by Fib-4 Index from subclinical subjects. Gastro Hep Adv 2023; 2: 170-81.
  22. Iwasaki Y, Tomiyama H, Shiina K, et al. Liver stiffness and arterial stiffness/abnormal central hemodynamics in the early stage of heart failure. Int J Cardiol Heart Vasc 2018; 20: 32-7.
  23. Yoshihisa A, Sato Y, Yokokawa T, et al. Liver fibrosis score predicts mortality in heart failure patients with preserved ejection fraction. ESC Heart Fail 2018; 5: 262-70.
  24. Cao Y, Guo S, Dong Y, et al. Comparison of liver fibrosis scores for predicting mortality and morbidity in heart failure with preserved ejection fraction. ESC Heart Fail 2023; 10: 1771-80.
  25. Tsuda K, Maeda D, Kanzaki Y, et al. Fibrosis-4 index identifies worsening renal function associated with adverse outcomes in acute heart failure. ESC Heart Fail 2023; 10: 1726-34.
  26. Kawahira M, Tamaki S, Yamada T, et al. Prognostic value of impaired hepato-renal function and liver fibrosis in patients admitted for acute heart failure. ESC Heart Fail 2021; 8: 1274-83.
  27. Maeda D, Kanzaki Y, Sakane K, et al. Prognostic impact of a reduction in the fibrosis-4 index among patients hospitalized with acute heart failure. Heart Vessels 2023; 38: 1235-43.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
SUBMIT YOUR PAPER
Share
without publication fees
Indexed in
pubmed
Integrated with
integrated with publons
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications